Table 1 Patient demographics and clinical characteristics.

From: Urinary fatty acid binding protein 3 (uFABP3) is a potential biomarker for peripheral arterial disease

Variable

Non-PAD (n = 65)

PAD (n = 65)

p-valueα

Median (IQR)†

ABI

1.06 (1.00–1.13)

0.52 (0.45–0.69)

0.001

Age in years

56 (43–68)

72 (65–80)

0.001

eGFR

88 (72.5–99.5)

86 (69.0–92.0)

0.293

Frequency, n (%)‡

Sex-male

36 (55)

45 (69)

0.103

Hypertension

30 (46)

50 (77)

0.001

Hypercholesteremia

23 (35)

49 (75)

0.001

Diabetes

10 (15)

33 (51)

0.001

Smoking

39 (60)

54 (83)

0.004

History of CAD

7 (11)

28 (44)

0.001

History of stroke

1 (2)

10 (15)

0.005

  1. Medians and interquartile ranges (IQR) were calculated for continuous variables.
  2. Frequencies and percentages were calculated for categorical variables; all numbers were rounded up with zero decimal place.
  3. All p-values were rounded to three decimal places.
  4. ABI ankle brachial index, eGFR estimated glomerular filtration rate.
  5. αThe significance of the difference between PAD and non-PAD groups.
  6. †Differences between groups were compared using Mann–Whitney test.
  7. ‡Differences between groups were compared using chi-square test.
Back to article page